N-Ethyl-2-nitro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)aniline, 96%, 5g

(3-Fluoro-5-(hydroxymethyl)phenyl)boronic acid, 97%, 5g

4-Chlorostyrene (stabilised with TBC), 99.00%, 1g

3-(2-(2-BROMOETHOXY)ETHOXY)PROP-1-YNE, 95%, 100mg

Ethyl 3-(3-chlorophenyl)-3-cyano-2-oxopropanoate, 95.0%, 1g

(4-{[4-(1H-benzimidazol-2-yl)piperidin-1-yl]sulfonyl}phenyl)amine, 95.0%, 1g

Feuille de cuivre (OFHC) 99,95+% 0,25 x 150 x 150 mm 1 pc

1,3,5-Trimethoxybenzene, 95.0%, 100g

Quinoxalin-6-ylmethanamine dihydrochloride, 98%, 250mg

TERT-BUTYL HEXAHYDROCYCLOPENTA[C]PYRROLE-2(1H)-CARBOXYLATE, 95.0%, 1g

tert-Butyl 4-fluoro-2-oxo-1H-spiro[indole-3,4'-piperidine]-1'-carboxylate, 100mg

3-(2-methylpiperazin-1-yl)propanenitrile, 95.0%, 1g

Azelaic acid, 98.00%, 1kg